PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|June 29, 2015
Colorcon Adds Lab in Beijing
Author(s)Pharmaceutical Technology Editors
Colorcon expands its presence in China with a technical service center to serve the northern region.
Advertisement
Colorcon has announced that the company opened a new technical service laboratory in Beijing, China on June 25. Located in the Beijing YiZhuang Biomedical Park, the technical center is the company’s second facility in China and 19th worldwide.
Equipped for research-scale solid dose development, the laboratory support the development and commercialization pharmaceutical drug formulations from initial product concept, to pilot scale trials through to final production and registration.
The company established Shanghai Colorcon Coating Technology Limited in 1993 and made additional strategic investments in China in a supply chain and the local manufacture of Opadry film coatings.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement